Literature DB >> 26471995

Characterization of Cep85 - a new antagonist of Nek2A that is involved in the regulation of centrosome disjunction.

Canhe Chen, Fang Tian, Lin Lu, Yun Wang, Zhe Xiao, Chengtao Yu, Xianwen Yu.   

Abstract

Entities:  

Year:  2015        PMID: 26471995      PMCID: PMC6295115          DOI: 10.1242/jcs.180463

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


× No keyword cloud information.
  2 in total

1.  NIMA-related kinase 2 overexpression is associated with poor survival in cancer patients: a systematic review and meta-analysis.

Authors:  Yang Yao; Jie Su; Lei Zhao; Na Luo; Lihui Long; Xingmei Zhu
Journal:  Cancer Manag Res       Date:  2019-01-03       Impact factor: 3.989

2.  Pathogenic Variants in CEP85L Cause Sporadic and Familial Posterior Predominant Lissencephaly.

Authors:  Meng-Han Tsai; Alison M Muir; Won-Jing Wang; Yi-Ning Kang; Kun-Chuan Yang; Nian-Hsin Chao; Mei-Feng Wu; Ying-Chao Chang; Brenda E Porter; Laura A Jansen; Guillaume Sebire; Nicolas Deconinck; Wen-Lang Fan; Shih-Chi Su; Wen-Hung Chung; Edith P Almanza Fuerte; Michele G Mehaffey; Ching-Ching Ng; Chung-Kin Chan; Kheng-Seang Lim; Richard J Leventer; Paul J Lockhart; Kate Riney; John A Damiano; Michael S Hildebrand; Ghayda M Mirzaa; William B Dobyns; Samuel F Berkovic; Ingrid E Scheffer; Jin-Wu Tsai; Heather C Mefford
Journal:  Neuron       Date:  2020-02-24       Impact factor: 17.173

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.